Pharmacokinetics of levofloxacin in goats, following oral administration (4 mg/kg) was evaluated in trikatu pretreated goats. Reverse-phase High Performance Liquid Chromatography (HPLC) was applied for determination of levofloxacin concentration in plasma concentration. Maximum plasma concentration (C max ), elimination halflife (t 1/2 ), volume of distribution (Vd area ), total body clearance (Cl B ) and bioavailability were 0.60 ± 0.03 g/ml, 0.95 ± 0.07 h, 1.91 ± 0.11 l/kg, 1.06 ± 0.06 l/h/kg and 21.49 %, respectively observed after oral administration of levofloxacin in goats. In trikatu pretreated goats, pharmacokinetic parameters, viz., maximum plasma concentration (C max ), elimination half-life (t 1/2 ), volume of distribution (Vd area ), total body clearance (Cl B ) and bioavailability were reported as 0.74 ± 0.03 g/ml, 2.07 ± 0.15 h, 2.98 ± 0.26 l/kg, 1.02 ± 0.04 l/h/kg and 30.16 %, respectively. In conclusion, significant difference was observed in majority of pharmacokinetic data of levofloxacin in trikatu pretreated goats than those in normal goats. Trikatu pretreatment in goats significantly increased bioavailability of levofloxa cin.